Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa

被引:25
作者
Amirfar, Sam
Hollenberg, James P.
Karim, Salim S. Abdool
机构
[1] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[2] Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA
[3] Univ KwaZulu Natal, CAPRISA, Durban, South Africa
[4] Columbia Univ, Div Epidemiol, New York, NY USA
关键词
cost-effectiveness; decision analysis; HIV/AIDS; perinatal transmission; vaccine;
D O I
10.1097/01.qai.0000230526.79341.83
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To assess the potential impact over 10 years of a partially effective HIV vaccine in a cohort of 15-year-old adolescent girls in South Africa in terms of HIV infections and deaths prevented in mothers and infants. Methods: A computer simulation was constructed using a population of all 15-year-old adolescent girls in South Africa followed for 10 years. A partially effective vaccine is introduced into this population with the ability to reduce the HIV incidence rates of the adolescents and vertical transmission to their infants through birth and breast-feeding. At the end of this 10 year period, the number of HIV infections and death prevented in adolescents and infants is analyzed. Results: Using a 5% HIV incidence rate, a 50% effective vaccine decreases the number of HIV cases among adolescents by 57,653 (28.7%) and the number of cases among infants by 13,765 (28.9%) over 10 years. In addition, assuming a vaccine cost of $20 per dose, the vaccination program can save approximately $120 million for the South African government over 10 years. Conclusion: A partially effective HIV vaccine has an important role in HIV prevention in adolescents and infants in South Africa irrespective of other public policy implementations.
引用
收藏
页码:219 / 225
页数:7
相关论文
共 36 条
[1]   POTENTIAL IMPACT OF LOW EFFICACY HIV-1 VACCINES IN POPULATIONS WITH HIGH-RATES OF INFECTION [J].
ANDERSON, RM ;
SWINTON, J ;
GARNETT, GP .
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1995, 261 (1361) :147-151
[2]  
*ASSA, ASSA AIDS DEM MOD
[3]  
Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4
[4]   Modeling the economic benefits of an AIDS vaccine [J].
Bishai, D ;
Lin, MK ;
Kiyonga, CWB .
VACCINE, 2001, 20 (3-4) :526-531
[5]  
BLECHER M, 2004, S AFRICAN HLTH REV 2
[6]  
Bogard E, 2002, J ACQ IMMUN DEF SYND, V29, P132, DOI 10.1097/00042560-200202010-00004
[7]   The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis [J].
Brocklehurst, P ;
French, R .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (08) :836-848
[8]  
Cleary S, 2004, COST EFFECTIVENESS A
[9]  
*COUNC MED SCHEM, 2004, ANN REP REG MED SCH
[10]   Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women [J].
Fawzi, W ;
Msamanga, G ;
Renjifo, B ;
Spiegelman, D ;
Urassa, E ;
Hashemi, L ;
Antelman, G ;
Essex, M ;
Hunter, D .
AIDS, 2001, 15 (09) :1157-1165